ClinicalTrials.Veeva

Menu

Measured Hypocretin Levels and Recovery After Hip Surgery

Stanford University logo

Stanford University

Status

Unknown

Conditions

Osteoarthritis, Hip

Study type

Observational

Funder types

Other

Identifiers

NCT01009710
SU-07162009-3301
16339

Details and patient eligibility

About

A specific group of neurons in the brain produces hypocretin, a peptide which has been established as an important regulator of sleep and wakefulness. Activation of these neurons (increased hypocretin) stabilizes wakefulness; impairing or blocking these neurons (decreased hypocretin) promotes sleep. Evidence suggests that these neurons may be involved in the hypnotic properties of several anesthetics, and play a role in the induction and emergence from anesthesia. In humans there is a considerable inter-individual variability in hypocretin levels. This study aims to investigate how hypocretin levels affect the anesthetic care and recovery of patients undergoing elective hip surgery.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:- Adult (18 years of age or older)

  • Male or female
  • Scheduled for elective total hip arthroplasty at the Stanford Orthopedic Clinic.
  • Comprehend spoken and written English Exclusion Criteria:- ASA physical status > III (patients with severe systemic disease)
  • Diagnosed psychiatric disease (except mild depression)
  • Any diagnoses CNS disease or dementia
  • History of stroke
  • History of untreated thyroid disease
  • Difficulty in airway management (ventilation and/or intubation)
  • Body Mass Index (BMI) > 35 kg/m2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems